Speaker: 

Evan Liddington, PharmD, MBA - Hem/Onc Clinical Pharmacist, Geisinger​ - has nothing to disclose.

Yijie Cheng, PharmD - Hem/Onc Clinical Pharmacist, Geisinger​ - has nothing to disclose.

Moderator: 

Tristan Maiers, PharmD, BCOP, Central Region Hematology/Oncology Pharmacy Manager - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Summarize BiTEs on the current Geisinger Formulary

• Outline updated BiTE Therapy Operational Procedure Policy

• Discuss update to BiTE Therapy Toxicity Management Guideline Policy

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Tristan Maiers, PharmD, BCOP, Rajiv Panikkar, MD, Michele Long, BSN, Jaime Weeder, NP, Erika Bross, PA, and Jeanne Braunstein, CphT have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None.